RVL Pharmaceuticals PLC (RVLPQ)
0.00
USD |
OTCM |
Apr 26, 16:00
RVL Pharmaceuticals Total Assets (Quarterly): 85.40M for June 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 85.40M |
| March 31, 2023 | 111.11M |
| December 31, 2022 | 128.51M |
| September 30, 2022 | 155.36M |
| June 30, 2022 | 124.83M |
| March 31, 2022 | 144.31M |
| December 31, 2021 | 144.67M |
| September 30, 2021 | 109.55M |
| June 30, 2021 | 335.01M |
| March 31, 2021 | 355.17M |
| December 31, 2020 | 370.95M |
| Date | Value |
|---|---|
| September 30, 2020 | 427.25M |
| June 30, 2020 | 462.70M |
| March 31, 2020 | 475.13M |
| December 31, 2019 | 463.26M |
| September 30, 2019 | 494.17M |
| June 30, 2019 | 643.84M |
| March 31, 2019 | 776.15M |
| December 31, 2018 | 795.62M |
| September 30, 2018 | 855.47M |
| June 30, 2018 | 858.30M |
| December 31, 2017 | 919.74M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
85.40M
Minimum
Jun 2023
643.84M
Maximum
Jun 2019
295.95M
Average
335.01M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 69.08M |
| Shareholders Equity (Quarterly) | 16.33M |
| Debt to Equity Ratio | 3.537 |
| Current Ratio | 0.3765 |
| Net Debt Paydown Yield | -4.00% |